Apollon Formularies (AQSE:APOL) Days Payable : 0.00 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Days Payable?

Apollon Formularies's average Accounts Payable for the six months ended in Jun. 2023 was £0.87 Mil. Apollon Formularies's Cost of Goods Sold for the six months ended in Jun. 2023 was £0.00 Mil.

The historical rank and industry rank for Apollon Formularies's Days Payable or its related term are showing as below:

During the past 11 years, Apollon Formularies's highest Days Payable was 4197.50. The lowest was 66.66. And the median was 89.64.

AQSE:APOL's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 89.33
* Ranked among companies with meaningful Days Payable only.

Apollon Formularies's Days Payable stayed the same from Dec. 2021 (0.00) to Jun. 2023 (0.00).

Apollon Formularies Days Payable Historical Data

The historical data trend for Apollon Formularies's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Days Payable Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Days Payable

Get a 7-Day Free Trial

66.66

95.37

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Days Payable	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Apollon Formularies's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Days Payable distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Days Payable falls into.

Apollon Formularies Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Apollon Formularies's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as

	Days Payable (A: Dec. 2021 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2020 )	+	Accounts Payable (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (0.001	+	0.032)	/	2 )	/	0	*	365
=	0.0165					/	0	*	365
=	N/A

Apollon Formularies's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (0.619	+	1.113)	/	2 )	/	0	*	365 / 2
=	0.866					/	0	*	365 / 2
=	N/A

Apollon Formularies Days Payable Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.